Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

---

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

---

 

FORM 6-K

 

---

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

October 15, 2024

 

Commission File Number: 001-38159

---

 

BRITISH AMERICAN TOBACCO P.L.C.

(Translation of registrant’s name into English)

---

 

Globe House

4 Temple Place

London WC2R 2PG

United Kingdom
(Address of principal executive office)

---

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒              Form 40-F ☐

 

 

 

---

 

---

 

This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of October 15, 2024.

EXHIBIT INDEX

 

Exhibit		Description
Exhibit 1		Press Release entitled “Transaction in own shares” dated October 15, 2024.
Exhibit 2		Press Release entitled “BAT Capital Markets Day” dated October 15, 2024.

  

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

	British American Tobacco p.l.c.
	By:	/s/ Christopher Worlock
		Name:	Christopher Worlock
		Title:	Assistant Secretary

 

Date:  October 15, 2024

Exhibit 1

British American Tobacco p.l.c.

15 October 2024

TRANSACTION IN OWN SHARES

British American Tobacco p.l.c. (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 24 April 2024 it purchased the following number of its ordinary shares of 25 pence each ("shares") from Goldman Sachs International as part of its buyback programme announced on 18 March 2024:

Date of purchase:	14 October 2024
Number of ordinary shares of 25 pence each purchased:	64,650
Highest price paid per share (pence):	2,696.00p
Lowest price paid per share (pence):	2,685.00p
Volume weighted average price paid per share (pence):	2,690.43p

The Company intends to cancel the purchased shares.

Following the purchase and cancellation of these shares, the Company will have 2,213,775,507 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 133,271,256 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Goldman Sachs International on 14 October 2024 is set out below.

Enquiries:

Investor Relations

Victoria Buxton: [phone] | [e-mail]

Schedule of purchases - aggregate information

Issuer name	ISIN Code	Transaction date	Daily total volume (in number of shares)	Daily weighted average price of shares acquired	Platform
British American Tobacco p.l.c.	GB0002875804	14/10/2024	64,650	2,690.43p	LSE
British American Tobacco p.l.c.	GB0002875804	14/10/2024	0	0	CHIX
British American Tobacco p.l.c.	GB0002875804	14/10/2024	0	0	BATE

---

Schedule of purchases - individual transactions

Number of shares purchased	Transaction price (per share)	Market	Time of transaction
250	2691	XLON	08:51:49
50	2691	XLON	09:01:26
270	2691	XLON	09:01:26
1	2691	XLON	09:02:12
120	2691	XLON	09:02:18
256	2691	XLON	09:02:18
224	2692	XLON	09:04:00
276	2692	XLON	09:04:00
669	2692	XLON	09:04:43
100	2693	XLON	09:04:43
1	2692	XLON	09:06:39
284	2692	XLON	09:06:39
88	2691	XLON	09:06:39
91	2691	XLON	09:06:39
55	2691	XLON	09:06:39
13	2691	XLON	09:06:39
226	2691	XLON	09:06:39
250	2691	XLON	09:06:56
298	2691	XLON	09:08:12
250	2690	XLON	09:09:35
133	2691	XLON	09:11:12
525	2691	XLON	09:11:12
405	2692	XLON	09:13:31
429	2691	XLON	09:13:45
349	2691	XLON	09:14:47
456	2690	XLON	09:15:35
288	2690	XLON	09:16:59
267	2689	XLON	09:17:22
408	2689	XLON	09:21:10
274	2688	XLON	09:26:04
263	2689	XLON	09:26:13
271	2689	XLON	09:27:20
262	2688	XLON	09:27:54
268	2687	XLON	09:28:06
250	2686	XLON	09:28:36
273	2685	XLON	09:29:48
507	2687	XLON	09:31:02
311	2689	XLON	09:32:23
293	2688	XLON	09:32:36
352	2688	XLON	09:34:15
361	2687	XLON	09:34:41
292	2688	XLON	09:35:51
337	2687	XLON	09:37:17
315	2687	XLON	09:40:10

---

271	2688	XLON	09:41:35
264	2687	XLON	09:42:25
257	2690	XLON	09:45:39
251	2689	XLON	09:47:01
276	2688	XLON	09:51:00
256	2688	XLON	09:55:06
119	2687	XLON	09:55:24
140	2687	XLON	09:55:24
275	2687	XLON	09:56:37
368	2687	XLON	09:58:03
340	2688	XLON	10:04:51
323	2687	XLON	10:04:51
433	2686	XLON	10:04:51
131	2689	XLON	10:07:40
865	2689	XLON	10:07:40
768	2688	XLON	10:10:43
214	2688	XLON	10:12:59
5	2688	XLON	10:12:59
634	2689	XLON	10:15:11
268	2688	XLON	10:15:14
425	2688	XLON	10:23:25
231	2688	XLON	10:23:25
212	2687	XLON	10:26:02
547	2687	XLON	10:26:02
62	2688	XLON	10:28:00
218	2688	XLON	10:28:00
9	2688	XLON	10:31:25
1	2688	XLON	10:31:25
3	2688	XLON	10:31:25
7	2688	XLON	10:31:32
3	2688	XLON	10:31:32
285	2688	XLON	10:32:14
18	2688	XLON	10:35:24
3	2688	XLON	10:35:24
37	2688	XLON	10:35:56
193	2688	XLON	10:36:57
251	2687	XLON	10:38:11
215	2688	XLON	10:47:11
200	2688	XLON	10:50:34
253	2688	XLON	10:50:34
243	2687	XLON	10:55:00
174	2687	XLON	10:56:39
108	2689	XLON	11:04:05
851	2689	XLON	11:04:05
941	2691	XLON	11:06:13
20	2691	XLON	11:12:05
918	2691	XLON	11:12:05
929	2691	XLON	11:25:11

---

969	2691	XLON	11:29:03
760	2691	XLON	11:30:29
943	2690	XLON	11:32:40
78	2689	XLON	11:39:53
852	2689	XLON	11:39:53
867	2689	XLON	11:42:31
70	2690	XLON	11:51:23
923	2690	XLON	11:51:23
300	2689	XLON	11:51:39
395	2690	XLON	11:55:30
57	2690	XLON	11:55:30
203	2690	XLON	11:55:30
42	2690	XLON	11:55:30
261	2690	XLON	11:55:30
721	2690	XLON	11:55:32
231	2689	XLON	11:56:31
334	2688	XLON	11:57:08
61	2687	XLON	11:58:45
60	2687	XLON	11:58:45
50	2687	XLON	11:58:45
15	2687	XLON	11:59:14
217	2687	XLON	11:59:14
210	2688	XLON	12:00:00
18	2688	XLON	12:00:03
16	2688	XLON	12:00:07
53	2688	XLON	12:00:08
23	2688	XLON	12:00:09
104	2688	XLON	12:00:09
976	2689	XLON	12:03:54
51	2688	XLON	12:03:54
249	2688	XLON	12:03:54
300	2690	XLON	12:13:08
463	2690	XLON	12:13:08
1	2690	XLON	12:18:15
759	2690	XLON	12:18:15
206	2691	XLON	12:24:45
292	2691	XLON	12:24:45
929	2692	XLON	12:29:11
925	2694	XLON	12:30:57
934	2693	XLON	12:34:36
302	2692	XLON	12:34:40
192	2692	XLON	12:34:40
457	2692	XLON	12:34:40
92	2691	XLON	12:37:25
940	2693	XLON	12:49:28
971	2692	XLON	12:51:02
925	2693	XLON	13:01:37
199	2692	XLON	13:04:49

---

26	2692	XLON	13:04:49
742	2692	XLON	13:08:33
59	2693	XLON	13:18:33
213	2693	XLON	13:18:33
101	2693	XLON	13:18:33
71	2693	XLON	13:18:33
52	2693	XLON	13:18:33
436	2693	XLON	13:18:33
7	2693	XLON	13:35:24
340	2693	XLON	13:35:24
593	2693	XLON	13:35:24
946	2692	XLON	13:39:30
980	2692	XLON	13:46:34
210	2694	XLON	13:51:35
327	2694	XLON	13:51:35
415	2694	XLON	13:51:35
148	2694	XLON	13:51:35
676	2695	XLON	13:53:57
120	2695	XLON	13:53:57
346	2695	XLON	13:57:45
123	2695	XLON	13:57:45
148	2695	XLON	13:57:45
185	2695	XLON	13:57:45
963	2694	XLON	13:58:22
58	2693	XLON	13:59:04
1	2693	XLON	13:59:04
920	2693	XLON	13:59:04
955	2692	XLON	14:01:02
996	2691	XLON	14:01:53
116	2690	XLON	14:02:16
841	2690	XLON	14:02:16
898	2689	XLON	14:06:23
943	2692	XLON	14:16:42
941	2691	XLON	14:21:17
34	2691	XLON	14:30:05
393	2691	XLON	14:30:05
777	2690	XLON	14:30:33
713	2689	XLON	14:30:39
258	2690	XLON	14:31:01
1744	2690	XLON	14:31:01
218	2690	XLON	14:31:18
495	2690	XLON	14:31:18
124	2696	XLON	15:02:19
3	2696	XLON	15:02:22
239	2696	XLON	15:02:22
133	2696	XLON	15:02:22
1	2696	XLON	15:02:22
88	2696	XLON	15:04:10

---

12	2696	XLON	15:04:10
50	2695	XLON	15:06:38

Exhibit 2

15 October 2024

BAT Capital Markets Day

On 16 October 2024, we will host a Capital Markets Day for institutional investors and analysts at our Innovation Centre in Southampton, UK. Chief Executive, Tadeu Marroco, and Chief Financial Officer, Soraya Benchikh, will be joined by the management team and senior leaders from across the Group to provide further detail on our transformation journey.

We are committed to Building a Smokeless World and becoming a predominantly smokeless¹ business by 2035. By providing smokers with access to a wide range of smokeless products, we can drive forward Tobacco Harm Reduction and, ultimately, make cigarettes a thing of the past.

Our well-established multi-category strategy, global footprint, and deep consumer insights are crucial drivers of this journey. Our latest Innovation Centre in Southampton, opened earlier this year, is home to many of our 1,750 scientists, who deliver the rigorous science and R&D that underpin our New Categories.

This event will demonstrate how BAT’s science, innovation, breadth of capabilities and people can combine to achieve a Smokeless World and deliver long-term sustainable value for all our stakeholders.

On track for full-year 2024 guidance

We remain on track to deliver low-single digit organic revenue and adjusted profit from operations growth in FY24. We will progressively improve our delivery to 3-5% organic revenue growth, and mid-single figure adjusted profit from operations growth, on an organic, constant currency basis² by 2026.  

Extrapolating current spot rates³, we anticipate currency translation to be a c.5% headwind on FY24 adjusted profit from operations. All other guidance is unchanged.

Event details

Presentations will start at 8:30am on 16 October 2024. There will also be a live webcast on www.bat.com/ir for attendees who wish to join the event virtually. A copy of the presentations, together with a video playback of the webcast, will be made available after the event via the same link, and on our refreshed BAT IR App.

For further information, please contact:

Media Centre

[phone] (24 hours) | [e-mail] | @BATplc

Investor Relations

Victoria Buxton: [phone]

Amy Chamberlain: [phone]

John Harney: [phone]

[e-mail]

Notes:

¹ Predominantly smokeless refers to our ambition to achieve 50% of Group revenue from our smokeless products by 2035. Smokeless refers to Non-Combustibles, including Vapour products, Heated Products, Modern Oral pouches and Traditional Oral.

² To supplement the Group's results presented in accordance with International Financial Reporting Standards (IFRS), the Group's Management Board, as the chief operating decision maker, reviews certain of its results, including revenue, and adjusted profit from operations, at constant rates of exchange, prior to the impact of businesses sold or held-for-sale in the case of revenue and adjusted profit from operations. Although the Group does not believe that these measures are a substitute for IFRS or other operating measures, the Group does believe that such results excluding the impact of businesses sold or to be held-for-sale provide additional useful information to investors regarding the underlying performance of the business on a comparable basis and in the case of the sale of the Group's businesses in Russia and Belarus, the impact these businesses had on revenue and profit from operations. Accordingly, the organic volume and financial measures appearing in this document should be read in conjunction with the Group's results as reported under IFRS and other operating measures.

³ Based on current exchange rates of USD/GBP 1.3075 as at close on 11 October 2024.

---

 

Important information

References in this announcement to ‘BAT’, ‘Group’, ‘we’, ‘us’ and ‘our’ when denoting opinion refer to British American Tobacco p.l.c. (BAT PLC) and when denoting business activity refer to BAT Group operating companies, collectively or individually as the case may be. This announcement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any BAT PLC shares or other securities.

Forward looking statements

This announcement contains certain forward-looking statements, including “forward-looking” statements made within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use of words or phrases such as “believe,” “anticipate,” “could,” “may,” “would,” “should,” “intend,” “plan,” “potential,” “predict,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “outlook”, “target” and similar expressions. These include statements regarding our intentions, beliefs or current expectations concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which the Group operates.

In particular, these forward-looking statements include statements regarding (i) our commitment to Building a Smokeless World and becoming a predominantly smokeless business by 2035 and (ii) statements under the heading “On track for full-year 2024 guidance.”

All such forward-looking statements involve estimates and assumptions that are subject to risks, uncertainties and other factors. It is believed that the expectations reflected in this announcement are reasonable but they may be affected by a wide range of variables that could cause actual results and performance to differ materially from those currently anticipated.

Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are uncertainties related to the following: the impact of competition from illicit trade; the impact of adverse domestic or international legislation and regulation; the inability to develop, commercialise and deliver the Group's New Categories strategy; the impact of supply chain disruptions; adverse litigation and dispute outcomes and the effect of such outcomes on the Group's financial condition; the impact of significant increases or structural changes in tobacco, nicotine and New Categories related taxes; translational and transactional foreign exchange rate exposure; changes or differences in domestic or international economic or political conditions; the ability to maintain credit ratings and to fund the business under the current capital structure; the impact of serious injury, illness or death in the workplace; adverse decisions by domestic or international regulatory bodies; changes in the market position, businesses, financial condition, results of operations or prospects of the Group; direct or indirect adverse impacts associated with climate change and the move towards a circular economy; and cyber security risks caused by the heightened cyber-threat landscape, and increased digital interactions with consumers, and changes to regulation.

Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and BAT undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on such forward-looking statements.

No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per share of BAT PLC for the current or future financial years would necessarily match or exceed the historical published earnings per share of BAT PLC.

Additional information concerning these and other factors can be found in BAT PLC filings with the U.S. Securities and Exchange Commission (SEC), including the Annual Report on Form 20-F for the financial year ended December 31, 2023 and Current Reports on Form 6-K, which may be obtained free of charge at the SEC’s website, http://www.sec.gov, and at the British American Tobacco website, http://www.bat.com.

---